Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 71205-042

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 71205-042). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-042-90 (Valsahctz 320 125mg)

Label for Valsartan HCTZ 320 mg / 12.5 mg film-coated tablets. The label shows a quantity of 90 tablets and states each tablet contains 320 mg of Valsartan USP and 12.5 mg of Hydrochlorothiazide USP. Manufactured by Aurobindo Pharma Limited and relabeled by Proficient Rx LP in Thousand Oaks, CA. Storage instructions indicate to keep at 25°C (77°F). Tablets are described as pink, oval-shaped, and debossed with 'L238' on one side.*

FDA Label Image

Figure 1 (Valsahctz Figur1)

A line chart depicting the probability of achieving systolic blood pressure (SBP) below 140 mmHg at Week 8. The x-axis represents baseline SBP in mmHg from 140 to 180, and the y-axis shows the percentage achieving target SBP, ranging from 0% to 100%. Four data series compare Valsartan and hydrochlorothiazide tablets 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo, with Valsartan and hydrochlorothiazide tablets showing the highest probability across baselines followed by Valsartan, Hydrochlorothiazide, and placebo respectively.*

FDA Label Image

Figure 2-3-4 (Valsahctz Figure2 3 4)

Three line graphs presenting the probability of achieving blood pressure targets at Week 8 for Valsartan and Hydrochlorothiazide tablets 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo groups. The first graph shows diastolic blood pressure <90 mmHg against baseline DBP (90-110 mmHg), the second shows systolic blood pressure <130 mmHg against baseline SBP (140-180 mmHg), and the third shows diastolic blood pressure <80 mmHg against baseline DBP (90-110 mmHg).*

FDA Label Image

Structure (Valsahctz Hctz)

Chemical structure of the active ingredient Valsartan and Hydrochlorothiazide, depicting a sulfonamide group attached to a chlorinated aromatic ring and extended heterocyclic components.*

FDA Label Image

Structure (Valsahctz Valsa)

Chemical structure of Valsartan, showing its molecular arrangement as part of the dual active ingredients Valsartan and Hydrochlorothiazide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.